ATE325344T1 - Zielsequenzen für synthetische moleküle und verfahren für deren verwendung - Google Patents

Zielsequenzen für synthetische moleküle und verfahren für deren verwendung

Info

Publication number
ATE325344T1
ATE325344T1 AT98953881T AT98953881T ATE325344T1 AT E325344 T1 ATE325344 T1 AT E325344T1 AT 98953881 T AT98953881 T AT 98953881T AT 98953881 T AT98953881 T AT 98953881T AT E325344 T1 ATE325344 T1 AT E325344T1
Authority
AT
Austria
Prior art keywords
target sequences
methods
synthetic molecules
sequences
molecules
Prior art date
Application number
AT98953881T
Other languages
English (en)
Inventor
Roger Y Tsien
Albert B Griffin
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/955,206 external-priority patent/US5932474A/en
Priority claimed from US08/955,050 external-priority patent/US6054271A/en
Priority claimed from US08/955,859 external-priority patent/US6008378A/en
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE325344T1 publication Critical patent/ATE325344T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/80—Heterocyclic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT98953881T 1997-10-21 1998-10-21 Zielsequenzen für synthetische moleküle und verfahren für deren verwendung ATE325344T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/955,206 US5932474A (en) 1997-10-21 1997-10-21 Target sequences for synthetic molecules
US08/955,050 US6054271A (en) 1997-10-21 1997-10-21 Methods of using synthetic molecules and target sequences
US08/955,859 US6008378A (en) 1997-10-21 1997-10-21 Synthetic molecules that specifically react with target sequences

Publications (1)

Publication Number Publication Date
ATE325344T1 true ATE325344T1 (de) 2006-06-15

Family

ID=27420732

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98953881T ATE325344T1 (de) 1997-10-21 1998-10-21 Zielsequenzen für synthetische moleküle und verfahren für deren verwendung

Country Status (5)

Country Link
EP (2) EP1684073A3 (de)
AT (1) ATE325344T1 (de)
AU (1) AU1113999A (de)
DE (1) DE69834420T2 (de)
WO (1) WO1999021013A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10046026A1 (de) 2000-09-18 2002-03-28 Basf Ag Verfahren zur Hydroformylierung, Xanthen-verbrückte Liganden und Katalysator, umfassend einen Komplex dieser Liganden
WO2005033286A2 (en) 2003-10-01 2005-04-14 Invitrogen Corporation Compositions and methods for synthesizing, purifying and detecting biomolecules
US20050239135A1 (en) 2003-10-24 2005-10-27 Bogoev Roumen A Compositions, methods and kits for biarsenical fluorophore labeling
WO2008109459A1 (en) 2007-03-02 2008-09-12 University Of Massachusetts Luciferins
US8097422B2 (en) 2007-06-20 2012-01-17 Salk Institute For Biological Studies Kir channel modulators
US7794963B2 (en) 2007-11-02 2010-09-14 E.I. Du Pont De Nemours And Company Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins
CA2767259A1 (en) 2009-07-09 2011-01-13 Verdezyne, Inc. Engineered microorganisms with enhanced fermentation activity
US8889394B2 (en) 2009-09-07 2014-11-18 Empire Technology Development Llc Multiple domain proteins
GB201019303D0 (en) 2010-11-15 2010-12-29 Strom Hans E P Agents and methods for visualising analytes
US8728798B2 (en) 2011-05-03 2014-05-20 Verdezyne, Inc. Biological methods for preparing adipic acid
CA2841796C (en) 2011-07-06 2021-06-29 Verdezyne, Inc. Biological methods for preparing a fatty dicarboxylic acid
WO2013076159A1 (en) 2011-11-22 2013-05-30 Imec Biarsenical nanoparticles for in vivo labeling
HK1215449A1 (zh) 2012-12-19 2016-08-26 沃德金有限公司 制备脂肪二羧酸的生物学方法
EP3129493B1 (de) 2014-04-09 2021-07-07 The Scripps Research Institute Import von unnatürlichen oder modifizierten nukleosid-triphosphaten in zellen mittels nukleinsäure-triphosphattransportern
US20180148744A1 (en) 2015-03-20 2018-05-31 Verdezyne, Inc. Biological methods for preparing 3-hydroxypropionic acid
TWI821192B (zh) 2017-07-11 2023-11-11 美商新索思股份有限公司 非天然核苷酸之導入及其方法
EP3652300A4 (de) 2017-07-13 2021-06-23 Radici Chimica S.p.A. Biologische verfahren zur modifizierung des zellulären kohlenstoffflusses
IL321812A (en) 2017-08-03 2025-08-01 Synthorx Inc Cytokine complexes for the treatment of autoimmune diseases
WO2020060948A1 (en) 2018-09-17 2020-03-26 Levadura Biotechnology, Inc. Production of cannabinoids in yeast using a fatty acid feedstock
MA54952A (fr) 2019-02-06 2022-05-11 Synthorx Inc Conjugués d'il-2 et méthodes d'utilisation de ceux-ci

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011694A1 (en) * 1993-10-26 1995-05-04 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
US6306663B1 (en) * 1999-02-12 2001-10-23 Proteinex, Inc. Controlling protein levels in eucaryotic organisms

Also Published As

Publication number Publication date
EP1032837B1 (de) 2006-05-03
EP1684073A2 (de) 2006-07-26
WO1999021013A1 (en) 1999-04-29
EP1684073A3 (de) 2007-09-26
DE69834420T2 (de) 2007-04-19
EP1032837A4 (de) 2001-11-14
AU1113999A (en) 1999-05-10
EP1032837A1 (de) 2000-09-06
DE69834420D1 (de) 2006-06-08

Similar Documents

Publication Publication Date Title
EP1032837A4 (de) Zielsequenzen für synthetische moleküle und verfahren für deren verwendung
DE59906513D1 (de) Verfahren zur vernetzung von hydrogelen mit bis- und poly-2-oxazolidinonen
DK1100880T3 (da) Urat oxidase
ATE549415T1 (de) Arrays und verfahren zur deren verwendung
DE69813158D1 (de) Assays zur Bestimmung von Proteinfragmenten in biologischen Medien
ATE392430T1 (de) Verfahren zur herstellung von dipeptiden
ATE532533T1 (de) Von antikörpern abgeleitete vektoren für den transfer von substanzen in zellen
ATE394484T1 (de) Smad 6 und dessen anwendungen
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
ATE14217T1 (de) Verfahren zur herstellung von n(tert.aminoalkyl)acrylamiden.
DE69632643D1 (de) Verwendungen von nukleinsäuren die ein retrovirus aus schweinen entnommen sind
DE69532033D1 (de) Für ein fibroblasten-aktivierungsprotein kodierende nukleinsäure und verwendungen dafür
DE69902796D1 (de) Verfahren zur reinigung von biomolekül- oder proteinkomplexen
WO2003094848A3 (en) Nucleic acid-associated proteins
ATE525462T1 (de) Proteomanalyseverfahren für phosphoryliertes protein
ATE301192T1 (de) Verwendung von neuronalem apoptose- inhibitorprotein
DE69934017D1 (de) 2,6-beta-d-fruktanhydrolase enzym und verfahren zu dessen verwendung
DE69924120D1 (de) Für ataxin-2-bindende proteine kodierende nukleinsäure, damit verwandten produkten und verfahren zur deren anwendung
WO2001038581A3 (en) Vigilance nucleic acids and related diagnostic, screening and therapeutic methods
DK0923644T3 (da) G-koblet receptor, der udviser selektiv selektivitet for ATP
DE69809930D1 (de) Isolierung und verwendung von nukleinsäuremolekülen, welche für mitglieder der ssx-familie kodieren
ATE332916T1 (de) Farbstoff-markiertes peptid und dessen verwendung zur diagnostik
ATE380239T1 (de) Verfahren zur spezifizitätsmodulierung von nitrilasen, nitrilasen aus diesem verfahren gewonnen und deren verwendung
EP1118659A4 (de) Expressionssysteme zur funktionellen expression von nukleinsäuren
DE69930294D1 (de) Minimale promotoren und ihre verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties